Physician profile
Thelma Cunningham
NPI 1992879522
$594.75
in general payments reported to CMS, 2019-2025
15 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $179 · 2021: $11.55 · 2023: $62.76 · 2024: $59.42 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.70 | 2019-2023 | Liletta |
| Organon LLC | $61.91 | 2024-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $60.94 | 2019-2023 | |
| Millicent US INC | $51.88 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Pfizer INC. | $48.01 | 2024-2025 | |
| Lupin INC. | $47.83 | 2020 | |
| Therapeuticsmd, INC. | $39.72 | 2019 | |
| Mylan Pharmaceuticals INC. | $37.18 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $24.33 | 2020 | |
| Ferring Pharmaceuticals INC. | $22.95 | 2019 | |
| Merck Sharp & Dohme LLC | $19.78 | 2020 | |
| Sage Therapeutics, LLC | $14.43 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $13.43 | 2020 | |
| Meditrina | $12.11 | 2023 | |
| Avion Pharmaceuticals | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thelma Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.